chr9:133748403:A>G Detail (hg19) (ABL1)

Go to:

Summary
Information
Links
Disease area statistics
MGeND
ClinVar
CIViC
DisGeNET
Annotation
Genome browser

Information

Genome

Assembly	Position
hg19	chr9:133,748,403-133,748,403
hg38	chr9:130,873,016-130,873,016 View the variant detail on this assembly version.

HGVS

ABL1

Type	Transcript	Protein
RefSeq	NM_005157.5:c.1064A>G	NP_005148.2:p.Glu355Gly
	NM_007313.2:c.1121A>G	NP_009297.2:p.Glu374Gly
Ensemble	ENST00000318560.6:c.1064A>G	ENST00000318560.6:p.Glu355Gly
	ENST00000372348.9:c.1121A>G	ENST00000372348.9:p.Glu374Gly

Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics	Show details

Frequency

[No Data.]

Prediction

ClinVar

Clinical Significance	Likely pathogenic
Review star
Show details

Links

ABL1

Type	Database	ID	Link
Gene	MIM	189980	OMIM
	HGNC	76	HGNC
	Ensembl	ENSG00000097007	Ensembl
	NCBI		NCBI
	Gene Cards		Gene Cards
	OncoKB		OncoKB

Type	Database	ID	Link
Variant	TogoVar
	COSMIC	COSM12611	COSMIC
	MONDO

Disease area statistics

[No Data.]

MGeND

[No Data.]

ClinVar

Clinical significance	Last evaluated	Review status	Condition	Origin	Links
Likely pathogenic	2015-07-14	no assertion criteria provided	chronic myelogenous leukemia, BCR-ABL1 positive	somatic	Detail

CIViC

Disease	Drug	EL	ET	ED	CS	VO	TR	Pubmed	Links
chronic myeloid leukemia	Bosutinib	C	Predictive	Does Not Support	Resistance	Somatic	1	21865346	Detail
chronic myeloid leukemia	Dasatinib	C	Predictive	Does Not Support	Resistance	Somatic	1	17264298	Detail
chronic myeloid leukemia	Dasatinib	B	Predictive	Does Not Support	Resistance	Somatic	2	19779040	Detail
chronic myeloid leukemia	Dasatinib	C	Predictive	Does Not Support	Resistance	Somatic	3	16775234	Detail
chronic myeloid leukemia	Imatinib Mesylate	D	Predictive	Supports	Resistance	Somatic	2	16772610	Detail
chronic myeloid leukemia	Imatinib Mesylate	C	Predictive	Supports	Resistance	Somatic	1	17264298	Detail

DisGeNET

[No Data.]

Annotation

Annotations

Descrption	Source	Links
In this retrospective study, imatinib-resistant or -intolerant patients, with chronic phase CML and ...	CIViC Evidence	Detail
In this phase II multinational study, patients with accelerated phase CML and BCR-ABL fusions were t...	CIViC Evidence	Detail
This is a retrospective study of imatinib-resistant (n = 805) or -intolerant (n = 238), chronic myel...	CIViC Evidence	Detail
Prior to dasatinib treatment, three imatinib-resistant patients with chronic myeloid leukemia had th...	CIViC Evidence	Detail
In an in vitro study, stochastic mutations were introduced into the ABL1 region of a stably expresse...	CIViC Evidence	Detail
In a phase II study of 60 imatinib-resistant patients with BCR-ABL mutations, 4 had E355G mutations	CIViC Evidence	Detail
NM_005157.6(ABL1):c.1064A>G (p.Glu355Gly) AND Chronic myelogenous leukemia, BCR-ABL1 positive	ClinVar	Detail

Overlapped Transcript Coordinates

Gene	Transcript ID	Exon Number	Chromosome	Start	Stop	Type	Amino Mutation	Transcript Position	Links

Overlapped Transcript

Gene	Transcript ID	Chromosome	Start	Stop	Links

Gene: -
dbSNP: rs121913450 dbSNP
Genome: hg19
Position: chr9:133,748,403-133,748,403
Variant Type: snv
Reference Allele: A
Alternative Allele: G
Variant (CIViC) (CIViC Variant): BCR-ABL E355G
Transcript 1 (CIViC Variant): ENST00000318560.5
Variant URL (CIViC Variant): https://civic.genome.wustl.edu/links/variants/1487

Genome browser